BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang R, Liu Z, Piao X, Zuo M, Zhang J, Liu Z, Li Y, Lin Y. Research progress on GP73 in malignant tumors. Onco Targets Ther 2018;11:7417-21. [PMID: 30425529 DOI: 10.2147/OTT.S181239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Wan YY. Golgi protein 73, hepatocellular carcinoma and other types of cancers. Liver Res 2020;4:161-7. [PMID: 33343966 DOI: 10.1016/j.livres.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wang M, Ren Y, Hu S, Liu K, Qiu L, Zhang Y. TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2. Front Oncol 2021;11:707032. [PMID: 34268128 DOI: 10.3389/fonc.2021.707032] [Reference Citation Analysis]
3 Shen JG, Shen J, Teng RY, Wang LB, Zhao WH, Wang QC. High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study. Pathol Oncol Res 2021;27:603838. [PMID: 34257562 DOI: 10.3389/pore.2021.603838] [Reference Citation Analysis]